TL1 Project Title: Evaluation of Nuanced Antibody Response to C-Terminal Peptide of ApoAI in Cardiovascular DiseasePatients with cardiovascular disease (CVD) possess IgG auto-antibodies targeting apolipoprotein A-I (ApoA-I), which correlates to poor CVD outcomes. Evaluation of these antibodies have focused on the IgG response to the full length unmodified protein. My project with Dr. Venditto will evaluate a much more nuanced immune response,... See More
Relating scientific principles and concepts to the prevention of disease
Jan 14 @ 12:00pm
(Luncheon)
Feb 11 @ 8:00pm
(Luncheon)
Feb 28 @ 12:00pm
Mar 6 @ 12:00pm
(Other)